<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d359">
    <sentence id="DDI-DrugBank.d359.s0" text="PEGANONE used in combination with other drugs known to adversely affect the hematopoietic system should be avoided if possible.">
        <entity charOffset="0-7" id="DDI-DrugBank.d359.s0.e0" text="PEGANONE" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s1" text="Considerable caution should be exercised if PEGANONE is administered concurrently with Phenurone (phenacemide) since paranoid symptoms have been reported during therapy with this combination.">
        <entity charOffset="44-51" id="DDI-DrugBank.d359.s1.e0" text="PEGANONE" type="brand"/>
        <entity charOffset="87-95" id="DDI-DrugBank.d359.s1.e1" text="Phenurone" type="brand"/>
        <entity charOffset="98-108" id="DDI-DrugBank.d359.s1.e2" text="phenacemide" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s1.e0" e2="DDI-DrugBank.d359.s1.e1" id="DDI-DrugBank.d359.s1.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s1.e0" e2="DDI-DrugBank.d359.s1.e2" id="DDI-DrugBank.d359.s1.p1" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d359.s1.e1" e2="DDI-DrugBank.d359.s1.e2" id="DDI-DrugBank.d359.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s2" text="A two-way interaction between the hydantoin antiepileptic, phenytoin, and the coumarin anticoagulants has been suggested.">
        <entity charOffset="34-56" id="DDI-DrugBank.d359.s2.e0" text="hydantoin antiepileptic" type="group"/>
        <entity charOffset="59-67" id="DDI-DrugBank.d359.s2.e1" text="phenytoin" type="drug"/>
        <entity charOffset="78-99" id="DDI-DrugBank.d359.s2.e2" text="coumarin anticoagulant" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s2.e0" e2="DDI-DrugBank.d359.s2.e1" id="DDI-DrugBank.d359.s2.p0" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s2.e0" e2="DDI-DrugBank.d359.s2.e2" id="DDI-DrugBank.d359.s2.p1" type="int"/>
        <pair ddi="false" e1="DDI-DrugBank.d359.s2.e1" e2="DDI-DrugBank.d359.s2.e2" id="DDI-DrugBank.d359.s2.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s3" text="Presumably, phenytoin acts as a stimulator of coumarin metabolism and has been reported to cause decreased serum levels of the coumarin anticoagulants and increased prothrombin-proconvertin concentrations.">
        <entity charOffset="12-20" id="DDI-DrugBank.d359.s3.e0" text="phenytoin" type="drug"/>
        <entity charOffset="46-53" id="DDI-DrugBank.d359.s3.e1" text="coumarin" type="group"/>
        <entity charOffset="127-149" id="DDI-DrugBank.d359.s3.e2" text="coumarin anticoagulants" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s3.e0" e2="DDI-DrugBank.d359.s3.e1" id="DDI-DrugBank.d359.s3.p0" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s3.e0" e2="DDI-DrugBank.d359.s3.e2" id="DDI-DrugBank.d359.s3.p1" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d359.s3.e1" e2="DDI-DrugBank.d359.s3.e2" id="DDI-DrugBank.d359.s3.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s4" text="Conversely, the coumarin anticoagulants have been reported to increase the serum levels and prolong the serum half-life of phenytoin by inhibiting its metabolism.">
        <entity charOffset="16-38" id="DDI-DrugBank.d359.s4.e0" text="coumarin anticoagulants" type="group"/>
        <entity charOffset="123-131" id="DDI-DrugBank.d359.s4.e1" text="phenytoin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s4.e0" e2="DDI-DrugBank.d359.s4.e1" id="DDI-DrugBank.d359.s4.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d359.s5" text="Although there is no documentation of such, a similar interaction between ethotoin and the coumarin anticoagulants may occur.">
        <entity charOffset="74-81" id="DDI-DrugBank.d359.s5.e0" text="ethotoin" type="drug"/>
        <entity charOffset="91-113" id="DDI-DrugBank.d359.s5.e1" text="coumarin anticoagulants" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d359.s5.e0" e2="DDI-DrugBank.d359.s5.e1" id="DDI-DrugBank.d359.s5.p0"/>
    <negationtags>Although there is &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; documentation of such, a similar interaction between ethotoin and the coumarin anticoagulants may occur. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d359.s6" text="Caution is therefore advised when administering PEGANONE to patients receiving coumarin anticoagulants.">
        <entity charOffset="48-55" id="DDI-DrugBank.d359.s6.e0" text="PEGANONE" type="brand"/>
        <entity charOffset="79-101" id="DDI-DrugBank.d359.s6.e1" text="coumarin anticoagulants" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d359.s6.e0" e2="DDI-DrugBank.d359.s6.e1" id="DDI-DrugBank.d359.s6.p0" type="advise"/>
    </sentence>
</document>